| Metric | შპს კრომოს ფარმა საქართველო | შპს ნეოლაბი |
|---|---|---|
| Growth | ||
| Revenue | ₾2.1m₾2.7m | ₾2.3m₾1.9m |
| Revenue growth | -23.2% | 21.5% |
| Profitability | ||
| EBITDA | ₾59k₾55k | -₾632k-₾787k |
| EBITDA margin | 2.8%2.0% | -26.9%-40.8% |
| Net profit | ₾24k₾10k | -₾643k-₾834k |
| Net margin | 1.1%0.4% | -27.4%-43.2% |
| Balance sheet | ||
| Total assets | ₾360k₾424k | ₾6.3m₾7.9m |
| Total equity | ₾317k₾294k | ₾6.2m₾7.7m |
| ROE | 7.5%3.5% | -10.4%-10.8% |